The Value of Free PSA in Addition to Total PSA
The Value of Diagnostics Tests in Detecting Cervical Cancer
The Value and Performance of 20/20`s Blood Test
The Valley Hospital Cancer Program
The validation of the treatment planning system BDTPS - INFN-LNL
The Validation of J-CAPRA Risk Assessment for Prostatic Cancer in
The utilization and impact of core needle biopsy diagnosis on breast
The Utility of Peripheral Blood Cultures in Diagnosis of Bacteremia
The uterus - Cancer Society NZ
The uterus - Cancer Society NZ
The Uterine Cancer Committee
The Use of Targeted Therapies for Precision
The use of recombinant human thyrotropin (Thyrogen) in the
The Use of Quality Measures in Colorectal Cancer Screening
The use of psychostimulants in palliative and supportive treatment of
The Use of PSA Doubling Time to Predict Prognosis and the Use of
The Use of Olaparib (AZD2281) Potentiates SN
The Use of Nanotechnology in Targeted Drug DELIVERY
the use of nanoparticles in the diagnosis and treatment of
The Use of Metformin and the Incidence of Lung Cancer in Patients
